מחקר: Heart Crossover (48)
48 מאמרים בנושא Heart Crossover, מאונדקסים על ידי PF-Atlas מ-PubMed וכתבי עת עולמיים.
מחקר בין-מחלתי. מחקרים אלה מתחומים פיברוטיים, אונקולוגיים או רגנרטיביים קשורים ובמעקב לשם רלוונטיות מנגנונית ל-IPF. הם אינם ראיה ישירה לטיפול בפיברוזיס ריאתי אידיופתי.
- Adipocyte Enhancer Binding Protein 1 Inhibition as a Potential Anti-Fibrotic Therapy in Heart Failure. · Research square · 2026
- Effect of anti-fibrotic therapy on regression of myocardial fibrosis after TAVI: design and rationale of the Reduce-MFA DZHK25 trial. · ESC heart failure · 2026
- Effective Transcatheter Mitral Valve Repair for Reverse Remodeling in Cancer Therapy-Related Cardiac Dysfunction. · International heart journal · 2026
- Oridonin as a novel KDM5C inhibitor alleviates clonal hematopoiesis-induced cardiac aging via H3K4me3-dependent SASP suppression. · Acta pharmaceutica Sinica. B · 2026
- Sacubitril/Valsartan Improves Functional Capacity and Reverses LV Remodeling in Obese Patients with Hypertrophic HFpEF: A Randomized Open-Label Study. · Journal of clinical medicine · 2026
- FAP-targeted gastrodin nanoparticles in responsive hydrogel alleviate cardiac fibrosis via fibroblast metabolic reprogramming. · Bioactive materials · 2026
- Yiqi Huoxue formula relieves heart failure with reduced ejection fraction in calcium/calmodulin-dependent protein kinase Ⅱ delta B isoform and calcium/calmodulin-dependent protein kinase Ⅱ delta C isoform transgenic mice by inhibiting myocardial remodeling and enhancing calcium homeostasis. · Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 2026
- The many facets of cardiopulmonary complications in sickle cell disease. · Seminars in hematology · 2026
- Physiological, molecular, and histological evaluation of the effects of cobalamin on cardiac function in castrated rabbits. · Open veterinary journal · 2026
- Obesity-Associated Cardiac Fibrosis: Mechanisms and Emerging Therapeutic Targets. · Vascular health and risk management · 2026
- Heart Failure Pharmacotherapy Across the TAVR Continuum. · Journal of cardiac failure · 2026
- Heart Failure in Adult Congenital Heart Disease. · Methodist DeBakey cardiovascular journal · 2026
- Tanshinone IIA Ameliorates Heart Failure by Inhibiting Ferroptosis via the Sirt1/p53/GPX4 Signaling Pathway. · The American journal of Chinese medicine · 2026
- DNA/RNA Methylation-Driven Coronary Microvascular Dysfunction: Emerging Pathogenic Mechanisms and Therapeutic Opportunities for Heart Failure in Diabetes. · Cardiovascular drugs and therapy · 2026
- Qiliqiangxin Improves Cardiac Glucose Metabolism After Myocardial Infarction Through a HIF-1α/MIF/AMPK Axis. · Journal of cellular and molecular medicine · 2026
- Long non-coding RNAs as molecular hubs integrating inflammatory and osteogenic pathways in calcific aortic valve disease. · Frontiers in cardiovascular medicine · 2026
- Recent Advances in Understanding the Pathophysiology and Biomarkers of Diabetic Cardiomyopathy in Diabetes Mellitus: A Review. · Current cardiology reviews · 2026
- Paeoniflorin attenuates cardiac remodeling by targeting AKT1 and suppressing the AKT/NF-κB inflammatory axis. · Molecular biology reports · 2026
- Huangqi-Danshen Decoction Alleviates Cardiac Fibrosis Following Myocardial Infarction by Inhibiting USP22 to Enhance the Ubiquitination of BRD4. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2026
- The Role of Multimodality Imaging in Atrial Fibrillation and Heart Failure: From Patient Selection to Procedural Ablation Guidance. · Medicina (Kaunas, Lithuania) · 2026
- Eclipsed Mitral Regurgitation: Paroxysmal Reversible Severe Mitral Regurgitation Presenting with Recurrent Pulmonary Edema: A Case Report. · Cureus · 2026
- β3-AR/β-arrestin2 Interaction Triggers Cardiac Fibrosis Through JNK/c-Jun Pathway in Cardiac Fibroblasts. · Journal of cellular and molecular medicine · 2026
- Zhigancao decoction ameliorates ischemic heart failure-related ventricular arrhythmias through attenuation of transforming growth factor-β/Smad-associated myocardial fibrosis. · Journal of ethnopharmacology · 2026
- Association of Angiotensin Receptor Neprilysin Inhibitors Duration with Latent Remodeling Following Implantable Cardioverter Defibrillator Implantation. · Heart rhythm · 2026
- Transcriptomic Profiling Identifies MyD88 and Pik3r3 as Hub Genes Associated with the Anti-hypertrophic Effects of B-type Natriuretic Peptide. · Current drug targets · 2026
- Strategies for preventing and reversing atrial cardiomyopathy : current evidence, therapeutic targets, and future directions. A European Journal of Heart Failure expert consensus statement. · European journal of heart failure · 2026
- Reversible Advanced Liver Fibrosis in Pediatric Constrictive Pericarditis. · JACC. Case reports · 2026
- CAR-based immunotherapy for cardiac fibrosis: a new therapeutic frontier. · Ageing research reviews · 2026
- Biventricular arrhythmogenic cardiomyopathy due to a PKP2 mutation with severe heart failure and multifocal thromboembolism as the clinically apparent presentation: a case report. · European heart journal. Case reports · 2026
- Combination of genetic eNOS deficiency and high-fat diet induces reproducible cardiometabolic HFpEF. · Redox biology · 2026
- Farnesol mitigates post-infarction ventricular remodeling via pharmacological modulation of the SPHK2/S1P/SMAD3 axis. · European journal of pharmacology · 2026
- Dyssynchrony-Induced Cardiomyopathy in Children: Mechanisms, Diagnosis, and Contemporary Management. · Pediatric cardiology · 2026
- Cardiac microcurrent therapy in heart failure: Mechanistic rationale, early clinical evidence, and future directions. · Heart failure reviews · 2026
- Therapeutic potential of Relaxin-2 in Heart Failure with preserved Ejection Fraction . · bioRxiv : the preprint server for biology · 2026
- Genetic deletion of cytoglobin exacerbates cardiac hypertrophy and inhibits cardiac fibroblast activation independent of changes in blood pressure. · American journal of physiology. Heart and circulatory physiology · 2026
- Extracellular matrix and cytoskeletal reverse remodeling pathways are key drivers of myocardial recovery following left ventricular assist device therapy. · bioRxiv : the preprint server for biology · 2026
- Narrowing the QRS, Expanding the Function: Left Bundle Branch Pacing in Dilated Cardiomyopathy. · Journal of cardiovascular echography · 2026
- Reversing diastolic dysfunction in diabetes: a mitochondrial quality control-centric pharmacological approach. · Acta diabetologica · 2026
- Transcutaneous auricular vagus nerve stimulation alleviates chronic heart failure by targeting cathepsin K/p53-mediated ferroptosis. · Biology direct · 2026
- Distribution of diffuse myocardial fibrosis is uneven and associated with left ventricular function in severe aortic stenosis. · Open heart · 2026
- Adropin protects against cardiac remodeling and metabolic dysfunction in a male mouse HFpEF model. · Clinical science (London, England : 1979) · 2026
- Targeting S100A8/A9 Ameliorates Heart Failure with Preserved Ejection Fraction by Modulating TLR4/NF-κB-Mediated Inflammation. · Clinical and experimental pharmacology & physiology · 2026
- Septic cardiomyopathy: Fact or fiction? · American heart journal plus : cardiology research and practice · 2026
- Targeting Inflammation by Pioglitazone and its R-Enantiomer Mitigates Pathological Myocardial Remodeling in Murine Hypertrophic Cardiomyopathy. · JACC. Basic to translational science · 2026
- ECMO-Supported Pericardiectomy in Constrictive Tuberculous Pericarditis With Severe Ventricular Dysfunction. · JACC. Case reports · 2026
- Empagliflozin-pirfenidone dual therapy improves cardiac function and structure in a preclinical two-hit HFpEF model. · Frontiers in pharmacology · 2026
- Reframing medical therapy in the Fontan circulation: toward preservation of physiologic reserve and durability. · Cardiology in the young · 2026
- ACE inhibitors reduce the risk of myocardial fibrosis post-cardiac injury: a systematic review. · The British journal of cardiology · 2025
הבהרה רפואית. רשימות מחקר הן למידע בלבד ואינן ייעוץ רפואי.